GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (FRA:YB3) » Definitions » Deferred Policy Acquisition Costs

Shin Nippon Biomedical Laboratories (FRA:YB3) Deferred Policy Acquisition Costs


View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Shin Nippon Biomedical Laboratories (FRA:YB3) Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.